Caris Life Sciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Caris Life Sciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CAI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002019410
Board of directors
-
Brian J. Brille · Director · See RemarksSince 2025
-
David D. Halbert · Director · See RemarksSince 2025
-
David Paul Fredrickson · DirectorSince 2025
-
George Poste · DirectorSince 2025
-
Jeff L. Vacirca · DirectorSince 2025
-
Jon Halbert · DirectorSince 2025
-
Jonathan Kenneth Charles Knowles · DirectorSince 2025
-
Joseph E. Gilliam · DirectorSince 2025
-
Laura I. Johansen · DirectorSince 2025
-
Lloyd Minor · DirectorSince 2025
-
Peter M. Castleman · DirectorSince 2025
-
T. Danny Phillips · DirectorSince 2025
Board connections
2 of this board's directors also sit on 2 other boards.
- via Lloyd Minor
- via George Poste
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,601,870
- 4 purchases by 4 insiders
- Sold, last 12 months
- $28,859,013
- 7 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Denton John Russel Officer (See Remarks) | Open-market sale | −7,500 | $31.82 | $238,626 |
| Sep 17, 2026 | Brian J. Brille Director, Officer (See Remarks) | Option exercise | +400,000 | $2.44 | $976,000 |
| Sep 17, 2026 | Brian J. Brille Director, Officer (See Remarks) | Open-market sale | −400,000 | $30.33 | $12,132,080 |
| Sep 4, 2026 | Spetzler David Baxley Officer (President) | Option exercise | +250,000 | $2.44 | $610,000 |
| Sep 4, 2026 | Spetzler David Baxley Officer (President) | Open-market sale | −119,212 | $24.76 | $2,951,117 |
| Sep 3, 2026 | Spetzler David Baxley Officer (President) | Option exercise | +1,000,000 | $2.44 | $2,440,000 |
| Sep 3, 2026 | Spetzler David Baxley Officer (President) | Open-market sale | −393,100 | $24.76 | $9,733,313 |
| Sep 3, 2026 | Spetzler David Baxley Officer (President) | Open-market sale | −84,900 | $25.32 | $2,149,676 |
| Aug 14, 2026 | Peter M. Castleman Director | Grant or award | +13,192 | — | — |
| Aug 14, 2026 | Jon Halbert Director | Grant or award | +13,192 | — | — |
| Aug 14, 2026 | Laura I. Johansen Director | Grant or award | +13,192 | — | — |
| Aug 14, 2026 | T. Danny Phillips Director | Grant or award | +13,192 | — | — |
| Aug 14, 2026 | Joseph E. Gilliam Director | Grant or award | +13,192 | — | — |
| Aug 14, 2026 | Jeff L. Vacirca Director | Grant or award | +13,192 | — | — |
| Aug 14, 2026 | Lloyd Minor Director | Grant or award | +13,192 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.